RN7SL97P

Across TCGA pan-cancer cohorts, RN7SL97P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL97P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL97P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL97P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

LUAD, READ, and MESO are the cancer types where RN7SL97P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.232	0.558	<.001	117	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	117	view →
MESO	OS	Tertile	III,IV	0.098	0.579	.001	81	view →
SKCM	OS	Tertile	III,IV	0.458	0.822	<.001	54	view →
KIRC	DFS	Tertile	IV	0.231	0.643	<.001	54	view →
THCA	OS	Tertile	All	0.585	0.929	<.001	54	view →
LUSC	DFS	Tertile	All	0.503	0.808	.003	48	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
DLBC	OS	Tertile	All	0.526	0.936	.002	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RN7SL97P–LUAD (OS)

Open the LUAD breakdown →